Estrella Immunopharma Inc. (ESLA) — Strategic Asset Allocation Index
Estrella Immunopharma Inc. (ESLA) has a Strategic Asset Allocation Index of 0.5% as of December 2022. Strategic assets (PP&E of $34.52K plus long-term investments of $-) total $34.52K, measured against net assets of $7.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Estrella Immunopharma Inc. balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Estrella Immunopharma Inc. (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Estrella Immunopharma Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Estrella Immunopharma Inc. (ESLA) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|